Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomax Formulations is an Indian pharmaceutical company specializing in the development, manufacturing, and marketing of a wide range of finished dosage forms. The company's product portfolio includes tablets, capsules, liquid orals, and topicals across various therapeutic segments such as anti-infectives, analgesics, and metabolic disorders. Operating primarily as a manufacturer of generic formulations, Biomax serves both domestic and international markets with a focus on quality and affordability. The company maintains manufacturing facilities compliant with regional regulatory standards to support its diverse product line. Its business model encompasses both branded generics and contract manufacturing services for global partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomax Formulations.